Literature DB >> 12862195

Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom.

David K Whynes1, Emma J Frew, Robert Edwards, Wendy S Atkin.   

Abstract

OBJECTIVES: Colorectal cancer is one of the most commonly occurring cancers in industrialized countries, yet appears to be amenable to screening. Amongst the many possible protocols is once-only screening by means of flexible sigmoidoscopy. This protocol is currently being investigated in a UK multicenter trial and the study provides estimates of the expected resource costs.
METHODS: The direct health care costs of sigmoidoscopy and of all subsequent procedures were estimated from an audit of resource use of approximately 40,000 patients at thirteen centers. Patient-borne costs were estimated from the results of surveys conducted at twelve of these centers.
RESULTS: The health service costs of a flexible sigmoidoscopy was estimated at pounds 56. The total costs of screening (including private costs) averaged pounds 82 per person screened, although costs varied by center. The total health service costs of screening and subsequent management averaged approximately pounds 91 per person screened, again with variations between centers.
CONCLUSIONS: Even within a strict trial protocol, intercenter variation in costs can be detected, ascribable to variability in local management practices, local yield, and local patient-borne costs. Other recent estimates of flexible sigmoidoscopy costs vary widely. As these costs form the basis of technology assessment simulation models which, in turn, inform policy obtaining realistic cost estimates within the appropriate health care setting is of paramount importance.

Entities:  

Mesh:

Year:  2003        PMID: 12862195     DOI: 10.1017/s0266462303000345

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  7 in total

1.  Willingness-to-pay and demand curves: a comparison of results obtained using different elicitation formats.

Authors:  David K Whynes; Emma J Frew; Jane L Wolstenholme
Journal:  Int J Health Care Finance Econ       Date:  2005-12

2.  Option appraisal of population-based colorectal cancer screening programmes in England.

Authors:  Paul Tappenden; James Chilcott; Simon Eggington; Julietta Patnick; Hannah Sakai; Jonathon Karnon
Journal:  Gut       Date:  2006-12-01       Impact factor: 23.059

3.  Is There a Place for Screening Flexible Sigmoidoscopy?

Authors:  Doron Boltin; Yaron Niv
Journal:  Curr Colorectal Cancer Rep       Date:  2012-03

4.  Hospital costs of colorectal cancer care.

Authors:  D A L Macafee; J West; J H Scholefield; D K Whynes
Journal:  Clin Med Oncol       Date:  2009-03-20

5.  A cost analysis of colonoscopy using microcosting and time-and-motion techniques.

Authors:  Stephen G Henry; Reid M Ness; Renée A Stiles; Ayumi K Shintani; Robert S Dittus
Journal:  J Gen Intern Med       Date:  2007-07-31       Impact factor: 5.128

6.  Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.

Authors:  L Sharp; L Tilson; S Whyte; A O'Ceilleachair; C Walsh; C Usher; P Tappenden; J Chilcott; A Staines; M Barry; H Comber
Journal:  Br J Cancer       Date:  2012-02-16       Impact factor: 7.640

7.  Could CT screening for lung cancer ever be cost effective in the United Kingdom?

Authors:  David K Whynes
Journal:  Cost Eff Resour Alloc       Date:  2008-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.